2015
DOI: 10.1007/s00405-015-3815-2
|View full text |Cite
|
Sign up to set email alerts
|

A novel nasopharyngeal stent for the treatment of obstructive sleep apnea: a case series of nasopharyngeal stenting versus continuous positive airway pressure

Abstract: The objective of the study was to investigate the first-night treatment success of a nasopharyngeal stent compared to standard nCPAP-titration. This is a case series and a single-center study. Eight participants (n = 8) were selected with untreated obstructive sleep apnea with a prestudy AHI ≥ 10. A newly developed nasopharyngeal stent was tested individually versus standard nCPAP-titration. Cardiorespiratory polysomnography was performed on two consecutive nights (random order: stent, nCPAP). The AHI, the num… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 21 publications
0
10
0
Order By: Relevance
“…Study using the device shows a moderate decrease in the AHIs with correction of obstructive apneas and correction of apnea induced oxygen desaturation. The device though was not as effective as CPAP 104 .…”
Section: Computerized Surgical Planningmentioning
confidence: 79%
“…Study using the device shows a moderate decrease in the AHIs with correction of obstructive apneas and correction of apnea induced oxygen desaturation. The device though was not as effective as CPAP 104 .…”
Section: Computerized Surgical Planningmentioning
confidence: 79%
“…However, for potential effectiveness on UA obstruction, the distal tip should also theoretically reach an area within 1 cm of the epiglottis . Conversely, only few nasally administered devices actually target the oropharynx . A recent case series of eight patients treated with such a device reported a mean AHI reduction of 38.7% (AHI = 31.1 ± 12.0 vs. 19 ± 12.0) with the stent, in comparison to a mean reduction of 73.6% under CPAP (AHI = 8.2 ± 11.9) .…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, only few nasally administered devices actually target the oropharynx . A recent case series of eight patients treated with such a device reported a mean AHI reduction of 38.7% (AHI = 31.1 ± 12.0 vs. 19 ± 12.0) with the stent, in comparison to a mean reduction of 73.6% under CPAP (AHI = 8.2 ± 11.9) . Sufficiently long nasal trumpets are usually not used in general practice or research due to limited tolerability…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…An automated nasopharyngeal point-based registration that utilizes titanium spherical fiducials combined with EMT systems serves this purpose. A titanium nasal stent based on the AlaxoStent (Alaxo GmbH, Germany) normally used for breathing enhancement in patients [ 12 ]—served to elaborate minimally invasive positioning and stabilization of four spherical fiducials and isocentrically mounted magnetic position sensors in the nasopharynx prior to preoperative imaging (Fig. 2 ).…”
Section: Methodsmentioning
confidence: 99%